News

Malaria Prophylaxis: Destination Designates Drug

Publish date: April 21, 2011

 

FROM THE ANNUAL MEETING OF THE AMERICAN COLLEGE OF PHYSICIANS

Dr. Miller reported having financial relationships with Pfizer, Cubist Pharmaceuticals, GlaxoSmithKline, and Merck. He has been a consultant with Theravance.

Pages

Recommended Reading

Alternative Dosing Schedules for HPV Vaccine Found Immunogenic, Safe
MDedge Internal Medicine
Four-Drug Fixed-Dose Combo for TB Found Noninferior
MDedge Internal Medicine
Topical Suffocants Effective for Resistant Head Lice
MDedge Internal Medicine
S. aureus Is Transmitted From Mother to Neonate at Low Rate
MDedge Internal Medicine
Interventions to Reduce MRSA Have Conflicting Results
MDedge Internal Medicine
Probiotic Treatment Halves Recurrent UTI Risk
MDedge Internal Medicine
Alcohol Use Disorders Up Death Risk for Inpatients With Infections
MDedge Internal Medicine
Postop Probe Technique Cuts Abdominal Surgical Site Infections
MDedge Internal Medicine
Surgical Care Improvement Program Hasn't Improved Key Outcomes
MDedge Internal Medicine
FDA Sends Warning Letters to Four Hand Sanitizer Manufacturers
MDedge Internal Medicine